pain relief
AFT lifts profit guidance after weak start
Hikma Pharmaceutical’s first sale of Maxigesic IV in the US delivers boost for AFT Pharmaceuticals AFT Pharmaceuticals – the owner of the Maxigesic ibuprofen/paracetamol combination drug – has raised its …
The reasons for prescription opioid abuse
Distress and pain are the key reasons people are taking opioids in higher doses than prescribed or without a prescription, new research shows A study led by Monash University researchers, …
An unscheduled dilemma
In the first of our series of reviews of the biggest issues facing pharmacy in 2017, Megan Haggan looks at the fraught issue of the codeine upschedule There’s no doubt …
ACCC alleges misleading representation over Voltaren pain relief gels
GSK says it’s disappointed after the ACCC announced it was taking it and Novartis to court over alleged misleading representations The ACCC announced that it has instituted proceedings in the …
Research Roundup
Debbie Rigby rounds up the latest in research news Vitamin D supplementation to prevent asthma exacerbations A systematic review and meta-analysis of individual participant data (n=955) has concluded that Vitamin …
Who wants to be a millionaire?
Maxigesic has revealed their ‘Chance to win $1 Million’ winner – but how much did the lucky 19-year-old win? Tayla Laverty, 19, from Prospect in Tasmania, was drawn as a …
Targeting pain
Despite the downturn in the analgesics category, pharmacy’s trusted advice and proactive approach might just be the key to driving positive future growth According to Nielsen data, in the last …